Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-05-05 Heart Failure
Links
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSCMMG: Atrial Fibrillation
- LSCMMG: Heart Failure - Primary Care Guideline for the Use of SGLT-2 Inhibitors in Reduced Ejection Fraction Heart Failure
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- MHRA: SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
- MHRA: SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
- MHRA: SGLT2 inhibitors: updated advice on increased risk of lower-limb amputation (mainly toes)
- MHRA: SGLT2 inhibitors: updated advice on increased risk of lower-limb amputation (mainly toes)
- MHRA: SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis
- MHRA: SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction
- NICE TA731:Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
- NICE TA773: Empagliflozin for treating chronic heart failure with reduced ejection fraction
- NICE TA902: Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
- NICE TA929: Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction